ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 3229

Using Exome Sequencing to Identify Novel Genetic Associations with Granulomatosis with Polyangiitis Susceptibility

Angel C.Y. Mak1, Paul L.F. Tang2, Gang Xie3, Pui-Yan Kwok2, Paul A. Monach4, Simon Carette3, David Cuthbertson5, Gary S. Hoffman6, Nader A. Khalidi7, Curry L. Koening8, Carol A. Langford6, Carol A. McAlear9, Larry W. Moreland10, Christian Pagnoux3, Philip Seo11, Ulrich Specks12, Antoine G. Sreih13, Steven R. Ytterberg14, Peter A. Merkel15, Katherine A. Siminovitch3, Sharon A. Chung16 and Vasculitis Clinical Research Consortium, 1Cardiovascular Research Institute, University of California, San Francisco, San Francisco, CA, 2Institute for Human Genetics, University of California, San Francisco, San Francisco, CA, 3Mount Sinai Hospital, Toronto, ON, Canada, 4Rheumatology, Boston University School of Medicine, Boston, MA, 5Biostatistics and Informatics, Department of Pediatrics, University of South Florida, Tampa, FL, 6Rheumatology, Cleveland Clinic, Cleveland, OH, 7McMaster University, Hamilton, ON, Canada, 8Rheumatology, University of Utah, Salt Lake City, UT, 9University of Pennsylvania, Philadelphia, PA, 10Rheumatology & Clinical Immunology, University of Pittsburgh, Pittsburgh, PA, 11Division of Rheumatology, Johns Hopkins University, Baltimore, MD, 12Division of Pulmonary and Critical Care Medicine, Mayo Clinic College of Medicine, Rochester, MN, 13Department of Rheumatology, University of Pennsylvania, Philadelphia, PA, 14Rheumatology Division, Mayo Clinic, Rochester, MN, 15Division of Rheumatology, University of Pennsylvania, Philadelphia, PA, 16Russell/Englemen Rheumatology Research Center, Rosalind Russell / Ephraim P. Engleman Rheumatology Research Center, University of California, San Francisco, San Francisco, CA

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: genetics and vasculitis, Wegener's granulomatosis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 10, 2015

Title: Vasculitis IV

Session Type: ACR Concurrent Abstract Session

Session Time: 4:30PM-6:00PM

Background/Purpose: Previous genome-wide association studies of granulomatosis with polyangiitis (Wegener’s, GPA) identified common genetic variants associated with susceptibility to GPA.  However, since GPA is a rare disease, we hypothesize that rare genetic variants may be more strongly associated with disease susceptibility.  Therefore, we conducted an exome-sequencing study to identify rare, deleterious exonic variants associated with GPA. 

Methods: Seventy-seven individuals with GPA underwent exome sequencing using the Illumina HiSeq platform and the Nimblegen SeqCap EZ exome enrichment protocol. All cases of GPA were of European descent, c-ANCA/anti-PR3 positive, and fulfilled either the ACR Classification Criteria or the Chapel Hill Consensus Conference definition of GPA. Exome sequencing reads were processed according to the Genome Analysis Toolkit Best Practices for DNA sequencing. Variants were annotated and filtered with ANNOVAR and Variant Tools. Functional effects of the variant were assessed using in silico bioinformatics algorithms and databases of known pathogenic variants. We applied a gene burden test to identify genes that were enriched with deleterious variants in patients with GPA when compared to publicly available data from the 1000 Genomes and the National Institutes of Health-funded Exome Sequencing Projects. Pathway analysis was performed using the Gene Set Enrichment Analysis Molecular Signatures database.

Results: After quality control filtering and bioinformatics analysis, we identified 4,306 exonic, non-synonymous, deleterious variants in the 77 cases of GPA, of which 3,812 were rare (minor allele frequency <1%). After applying gene burden tests, we identified 153 genes not previously associated with GPA that were enriched with deleterious variants in GPA cases compared to controls. These genes fell into the following 3 groups (with overlap): 1) 98 genes were enriched with rare deleterious variants, 2) 35 genes with homozygous rare deleterious variants not present in controls, and 3) 42 genes enriched with common deleterious variants. Genes with the strongest evidence of enrichment for rare, deleterious variants include FOXD4L1, UMODL1, and PNKP.  Pathways over-represented by the 153 genes include the metabolism of lipoproteins and extracellular matrix organization.  Lastly, we found enrichment for 6 variants in 3 genes previously associated with GPA (ITGB2, RXRB, SERPINA1).

Conclusion: Our initial results indicate that exome sequencing can identify novel genetic associations with GPA beyond what has been previously observed in genome-wide association studies.  These associations implicate new biologic pathways that may contribute to the pathogenesis of disease. To our knowledge, this is the first study to utilize next-generation sequencing to assess for genetic variants associated with GPA susceptibility. The results from this study can be used to inform future genomic and translational investigations of this and other systemic vasculitides.


Disclosure: A. C. Y. Mak, None; P. L. F. Tang, None; G. Xie, None; P. Y. Kwok, None; P. A. Monach, None; S. Carette, None; D. Cuthbertson, None; G. S. Hoffman, None; N. A. Khalidi, None; C. L. Koening, None; C. A. Langford, None; C. A. McAlear, None; L. W. Moreland, None; C. Pagnoux, None; P. Seo, None; U. Specks, None; A. G. Sreih, None; S. R. Ytterberg, None; P. A. Merkel, None; K. A. Siminovitch, None; S. A. Chung, None.

To cite this abstract in AMA style:

Mak ACY, Tang PLF, Xie G, Kwok PY, Monach PA, Carette S, Cuthbertson D, Hoffman GS, Khalidi NA, Koening CL, Langford CA, McAlear CA, Moreland LW, Pagnoux C, Seo P, Specks U, Sreih AG, Ytterberg SR, Merkel PA, Siminovitch KA, Chung SA. Using Exome Sequencing to Identify Novel Genetic Associations with Granulomatosis with Polyangiitis Susceptibility [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/using-exome-sequencing-to-identify-novel-genetic-associations-with-granulomatosis-with-polyangiitis-susceptibility/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/using-exome-sequencing-to-identify-novel-genetic-associations-with-granulomatosis-with-polyangiitis-susceptibility/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology